Article Sidebar

Submitted
May 26, 2021
Published
May 26, 2021
Download
PDF
Statistic
Read Counter : 60 Download : 49

Main Article Content

Abstract

In the present research work pulsatile drug delivery system of Zileuton tablets were formulated by employing compression coating technology. Initially the core tablets were prepared by 30% concentrations of super disintegrates, the formulated core tablets were coated with the polymers (Ethyl cellulose, EudragitL-100, EudragitS-100) by using compression coating technology. All the  core  and  press  coated  tablet  formulations  were  subjected  to  various physical and chemical evaluation tests.. The drug delivery system was designed to deliver the drug at such a time when it could be most needful to patient of nocturnal asthma. The thickness, hardness and weight variation shown by all the tablet formulations were found within the official pharmacopoeial limits. In vitro release of Zileuton core tablet formulations F1 (Drug, SSG, Talc, Magnesium stearate, MCC pH 102) showed faster drug release after 15 mins. Faster drug release can be correlated with the high disintegration and friability observed in this study. The enteric coated formulations C1, C3, showed maximum drug release after 4 hour. Time dependent pulsatile drug delivery system has been achieved from tablet of formulation C3, C6 and C9 with 95.5%, 94.76% and 97.48 % respectively.

Keywords

Zileuton Super disintegrates Ethyl cellulose Pulsatile tablets

Article Details

How to Cite
Vancha Harish, K.Nagaraju, J.Subhash, & Dr.Nallathambi. (2021). Development of novel gastroretentive mucoadhesive pulsetile tablets for zileuton. International Journal of Research in Pharmacology & Pharmacotherapeutics, 5(3), 273-285. https://doi.org/10.61096/ijrpp.v5.iss3.2016.273-285
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Davis SS, Illum L. Drug delivery systems for challenging molecules. International Journal of Pharmaceutics 176, 1998, 1-8.
  2. [2]. Gennaro AR, ed. Remington. The Science and Practice of Pharmacy 20th ed. USA: Lippincott, Williams & Wilkins; 2000, 903-905.
  3. [3]. Burnside BA, GO X, Fiske K, Couch RA, Treacy DJ, Chang RK, Mc Guinness CM, Rudnic EM: US20036605300 2003.
  4. [4]. Bussemer T, Otto I, Bodmeier R. Pulsatile drug delivery systems Crit Rev. Therapeutic Drug Carrier Systems 18(5), 2001, 433-458.
  5. [5]. Yoshida R, Sakai K, Okano T, Sakurai Y. Pulsatile drug delivery systems using hydrogels. Advanced Drug Delivery Reviews 11, 1993, 85-108.
  6. [6]. Kikuchi A, Okano T. Pulsatile drug release control using hydrogels. Advanced Drug Delivery Reviews 54, 2002, 53-77.
  7. [7]. Gazzaniga A, Maroni A, Sangalli ME, Zema L. Time-controlled oral delivery systems for colon targeting. Expert Opinion on Drug Delivery 3, 2006, 583-597.
  8. [8]. Peppas NA, Leobandung W. Stimuli-sensitive hydrogels, ideal carriers for chronobiology and chronotherapy. Journal of Biomaterials Science, Polymer Edition 15, 2004, 125-144.
  9. [9]. Stubbe BG, DeSmedt SC, Demeester J. Programmed polymeric devices for pulsed drug delivery. Pharmaceutical Research 21, 2004, 1732-1740.
  10. [10]. Gazzaniga A, Palugan L, Foppoli A, Sangalli ME. Oral pulsatile delivery systems based on swellable hydrophilic polymers. European Journal of Pharmaceutics and Biopharmaceutics 68, 2008, 11-18.
  11. [11]. Shiwani S, Anshul DS, Roopa S. Pulsatile Drug Delivery System: A Review an Advanced Approach. International Journal of Pharmacy and Technology 3, 2011, 1179-1188.
  12. [12]. Lachman L, Lieberman HA, Kanig JL. The Theory and Practice of Industrial Pharmacy. Verghese Publishing House 3, 1991.